The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors: a meeting report

被引：10

作者：

Valentino, L. A. ^{[1
,2
]}

Carcao, M. ^{[3
]}

Mathew, P. ^{[4
]}

Leissinger, C. A. ^{[5
]}

Berntorp, E. ^{[6
]}

Blanchette, V. ^{[3
]}

Escuriola-Ettingshausen, C. ^{[7
]}

Ewenstein, B. ^{[8
]}

Ewing, N. ^{[9
]}

Gringeri, A. ^{[10
]}

Hoots, W. K. ^{[11
]}

Negrier, C. ^{[12
]}

机构：

[1] Rush Univ, Med Ctr, Hemophilia & Thrombophilia Ctr, Dept Pediat, Chicago, IL 60612 USA

[2] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA

[3] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada

[4] Univ New Mexico, Dept Pediat, Hlth Sci Ctr, Albuquerque, NM 87131 USA

[5] Tulane Univ, Med Ctr, Louisiana Ctr Bleeding & Clotting, New Orleans, LA USA

[6] Malmo Univ Hosp, Dept Coagulat Disorders, Malmo, Sweden

[7] JW Goethe Univ Hosp, Dept Pediat, Franklin, Germany

[8] Baxter Biosci, Westlake Village, CA USA

[9] City Hope Natl Med Ctr, Div Pediat, Duarte, CA 91010 USA

[10] Univ Milan, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan, Italy

[11] Univ Texas Med Sch, Dept Pediat, Houston, TX USA

[12] Hop Edouard Herriot, Hemophilia Ctr, Lyon, France

来源：

HAEMOPHILIA | 2009年 / 15卷 / 04期

关键词：

PROTHROMBIN COMPLEX CONCENTRATE; HIGH-RESPONDING INHIBITORS; RECOMBINANT FACTOR-VIIA; IMMUNE TOLERANCE; ACTIVITY FEIBA; INTRACRANIAL HEMORRHAGE; BLEEDING EPISODES; THERAPY; SAFETY; POPULATION;

D O I：

10.1111/j.1365-2516.2008.01953.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：959 / 965

页数：7

共 50 条

[1] Bypassing agent prophylaxis for preventing arthropathy in patients with inhibitors
Ewenstein, B. M.
Wong, W. -Y.
Schoppmann, A.
HAEMOPHILIA, 2010, 16 (01) : 179 - 180
[2] Bypassing agent regimens and costs for prophylaxis in patients with inhibitors
Gringeri, A.
HAEMOPHILIA, 2009, 15 (06) : 1336 - 1337
[3] Spanish Consensus Guidelines on prophylaxis with bypassing agents in patients with haemophilia and inhibitors
Fernanda Lopez-Fernandez, Maria
Altisent Roca, Carmen
Teresa Alvarez-Roman, Maria
Canaro Hirnyk, Mariana Isabel
Eva Mingot-Castellanos, Maria
Jimenez-Yuste, Victor
Cid Haro, Ana Rosa
Perez-Garrido, Rosario
Sedano Balbas, Carmen
THROMBOSIS AND HAEMOSTASIS, 2016, 115 (05) : 872 - 895
[4] Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors
Eva Mingot-Castellano, Maria
Teresa Alvarez-Roman, Maria
Fernanda Lopez-Fernandez, Maria
Altisent-Roca, Carmen
Isabel Canaro-Hirnyk, Mariana
Jimenez-Yuste, Victor
Rosa Cid-Haro, Ana
Perez-Garrido, Rosario
Sedano-Balbas, Carmen
EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (05) : 461 - 474
[5] BYPASSING AGENTS PROPHYLAXIS IN PATIENTS WITH HAEMOPHILIA AND INHIBITORS UNDERGOING SURGERY: A DECISION ANALYSIS IN SPAIN
Mareque, M.
Mingot, M. E.
Lopez, M. F.
Alvarez, M. T.
Garcia, J. P.
Oyaguez, I
VALUE IN HEALTH, 2017, 20 (09) : A550 - A551
[6] Prophylaxis in haemophilia patients with inhibitors
Leissinger, C. A.
HAEMOPHILIA, 2006, 12 : 67 - 72
[7] Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain
Mareque, Maria
Mingot-Castellano, Maria Eva
Lopez-Fernandez, Maria Fernanda
alvarez-Roman, Maria Teresa
Oyaguez, Itziar
EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (01) : 94 - 100
[8] Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors
Chai-Adisaksopha, Chatree
Nevitt, Sarah J.
Simpson, Mindy L.
Janbain, Maissaa
Konkle, Barbara A.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (09):
[9] FEIBA prophylaxis for patients with haemophilia and inhibitors
Valentino, L. A.
HAEMOPHILIA, 2006, 12 : 26 - 31
[10] Major orthopaedic surgery for a haemophilia patient with inhibitors using a new bypassing agent
Takedani, H.
Hirose, J.
Minamoto, F.
Kubota, M.
Kinkawa, J.
Noguchi, M.
HAEMOPHILIA, 2016, 22 (05) : E459 - E461

← 1 2 3 4 5 →